BlackRock Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
BIT
BFA
BlackRock Group's PFE Position: Q4 2016 in Review
BlackRock Group increased its Pfizer (PFE) stake by 11% in Q4 2016, buying an estimated $201M and bringing the position to 68,616,393 shares worth $2.11B. The position accounts for 1.01% of the portfolio, ranked #12.
BlackRock Group first reported a position in PFE in Q2 2013 and has held it in 15 quarters since. 2,059 funds tracked by Wall St. Rank hold PFE as of Q4 2016.
- BlackRock Group held 68,616,393 shares of Pfizer worth $2.11B as of Q4 2016.
- BlackRock Group bought 6,573,236 Pfizer shares in Q4 2016, an estimated $201M.
- Pfizer made up 1.01% of BlackRock Group's portfolio in Q4 2016, its #12 holding.
- BlackRock Group first reported a position in Pfizer in Q2 2013 and has held it in 15 quarters since.
- 2,059 funds tracked by Wall St. Rank held Pfizer as of Q4 2016.
Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.